Antibody Responses to Meningococcal Vaccine in Hematopoietic Cell Transplant Recipients with Veno-Occlusive Disease Treated with Eculizumab
Infect Chemother. 2025 Jun;57(2):310-315. doi: 10.3947/ic.2025.0030. ABSTRACT Treatment with eculizumab increases the risk of invasive meningococcal infection (IMI). We evaluated tetravalent meningococcal vaccine responses in …